These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 11307807

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD, Arneklev K, Goldhaber SZ, Spandorfer J, Halperin F, Horrow J.
    Arch Intern Med; 2006 Apr 24; 166(8):853-9. PubMed ID: 16636210
    [Abstract] [Full Text] [Related]

  • 4. Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years.
    Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D.
    J Am Coll Cardiol; 2009 Sep 08; 54(11):999-1002. PubMed ID: 19729116
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M, Cannegieter SC, Bollen WL, van der Meer FJ, van der Wall EE, Rosendaal FR.
    Arch Intern Med; 2009 Jul 13; 169(13):1203-9. PubMed ID: 19597069
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation.
    Pengo V, Cucchini U, Denas G, Davidson BL, Marzot F, Jose SP, Iliceto S.
    Thromb Haemost; 2010 Feb 13; 103(2):442-9. PubMed ID: 20076843
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Management of oral anticoagulant therapy in the real practice of an anticoagulation clinic: focus on atrial fibrillation.
    Poli D, Antonucci E, Lombardi A, Cecchi E, Gensini GF, Abbate R, Prisco D.
    Blood Coagul Fibrinolysis; 2005 Oct 13; 16(7):491-4. PubMed ID: 16175008
    [Abstract] [Full Text] [Related]

  • 12. Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
    Tincani E, Baldini P, Crowther MA, Zanasi A, Ferrari P, Cenci AM, Rioli G.
    Blood Coagul Fibrinolysis; 2009 Jan 13; 20(1):47-51. PubMed ID: 20523164
    [Abstract] [Full Text] [Related]

  • 13. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M, AFFIRM Investigators.
    Am Heart J; 2005 Apr 13; 149(4):650-6. PubMed ID: 15990748
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy).
    Palareti G, Manotti C, DAngelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Leali N, Poggi M, Legnani C, Musolesi S, Coccheri S.
    Thromb Haemost; 1997 Dec 13; 78(6):1438-43. PubMed ID: 9423791
    [Abstract] [Full Text] [Related]

  • 17. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL, SPORTIF Investigators.
    Am Heart J; 2006 Nov 13; 152(5):967-73. PubMed ID: 17070169
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.
    Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S.
    Circulation; 2007 May 29; 115(21):2689-96. PubMed ID: 17515465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.